S.V. Morozova, L.S. Karapetyan
INTEGRATED APPROACH TO THE TREATMENT OF PATIENTS WITH OTITIS EXTERNA
|
7-11 |
V.G. Radchenko, P.V. Seliverstov, V.F. Ivanova, S.I. Sitkin
ALGORITHM OF TREATMENT OF NON-ALCOHOLIC FATTY OF LIVER DISEASE AND THE ROLE OF MITOCHONDRIAL DYSFUNCTION IN ITS DEVELOPMENT
|
12-19 |
Ya.I. Ashikhmin (1), D.Yu. Schekochikhin (2)
RECOMMENDATION ON THE TREATMENT OF DYSLIPIDEMIA (ESC/EAS) 2016: FOCUS ON APPLICATION OF NON-STATIN LIPID-LOWERING THERAPY
|
20-25 |
I.A. Zolotovskaya, I.L. Davydkin
CHANGES IN ARTERIAL STIFFNESS AND ENDOTHELIAL DYSFUNCTION ON THE BACKGROUND OF ANTICOAGULANT THERAPY AFTER CARDIOEMBOLIC STROKE IN PATIENTS WITH ATRIAL FIBRILLATION
|
26-32 |
I.S. Belousova, N.N. Borovkov
THE POSSIBILITIES OF ANXIOLITHIC THERAPY OF ANXIETY-DEPRESSIVE SYNDROME IN PATIENTS ON PROGRAM HEMODIALYSIS
|
33-36 |
I.V. Maev, A.A. Samsonov, A.V. Semenova (Yashina), D.N. Andreev, A.G. Akselrod
NEW APPROACH TO THE PAIN RELIEF IN IRRITABLE BOWEL SYNDROME
|
38-44 |
S.G. Kanorsky, Yu.V. Borisenko
IVABRADIN AGAINST BISOPROLOL IN PATIENTS WITH CHRONIC HEART FAILURE AND PRESERVED LEFT VENTRICULAL EJECTION FRACTION
|
45-50 |
P.G. Shvarts (1), S.V. Popov (2), I.A. Zavalishin (1)
PATHOPHYSIOLOGICAL AND NEUROPHARMACOLOGICAL FEATURES OF THERAPY OF CHRONIC RETENTION OF URINE IN MULTIPLE SCLEROSIS
|
51-60 |
N.A. Shevkunova
THE USE OF ANTIBACTERIAL DRUGS DURING ORTHOPAEDIC ALIGNMENT WITH REMOVABLE LAMINAR DENTURES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TAKING INTO ACCOUNT THE RESULTS OF PCR-BASED DIAGNOSTICS
|
61-64 |
D.S. Bordin (1, 2), Yu.V. Embutnieks (1), I.N. Voynovan (1), S.V. Kolbasnikov (2)
THE ROLE OF PROBIOTICS IN THE TREATMENT OF HELICOBACTER PYLORI INFECTION
|
65-69 |
G.I. Nechayeva, T.V. Tkachenko, E.V. Semenova
THE USE OF DIURETICS IN ARTERIAL HYPERTENSION
|
70-74 |
M.E. Statsenko, S.V. Turkina, I.A. Tyshchenko, S.V. Fabritskaya, L.V. Poletaeva
POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY
|
75-80 |
E.V. Golovanova
ENDOGENOUS AMMONIA AS THE REASON OF “CIRCULUS VITIOSUS” IN PROGRESSION OF LIVER DISEASES
|
81-87 |